| Value | ₹1,162 Cr |
|---|
BSE filing, NSE: HINDZINC. Summary written from the filing by ALFA Finder's alert engine.
Hindustan Zinc Ltd: key numbers
- Share price
- ₹505.80
- Market cap
- ₹2,13,717 Cr
- Revenue (annual)
- ₹40,844 Cr
- Net profit (annual)
- ₹13,832 Cr
- P/E (TTM)
- 10.3×Sector 16.5×
- Promoter holding
- 60.71%+0.00% QoQ
- FII holding
- 2.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Zinc Ltd
All →Hindustan Zinc Earnings Call Transcript: Key Takeaways
Management reported record profitability driven by lowest-ever zinc production costs despite global volatility.
Hindustan Zinc Investor Presentation: Key Takeaways
Hindustan Zinc reported record Q2FY27 performance with revenue of ₹15,093 crore (up 77% YoY) and EBITDA of ₹9,285 crore. Growth driven by record production, higher metal prices, and significant silver profitability contribution (45%).
Hindustan Zinc Results Update
Hindustan Zinc posted record Q2 FY27 net profit of ₹6,412 crore and EBITDA of ₹9,285 crore. 1H revenue hit a record ₹28,840 crore.
Hindustan Zinc Q2 FY27 Results: Net Profit ₹6,412 Cr, Up 142.1% YoY
Hindustan Zinc Ltd reported revenue from operations of ₹15,093 Cr (+76.5% YoY) and net profit of ₹6,412 Cr (+142.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,412 Cr · +142.1% YoY
Hindustan Zinc Annual General Meeting
Hindustan Zinc's postal ballot concluded, with shareholders approving the appointment of Mr. Amarendu Prakash as Whole-time Director/CEO and Dr. Yogesh Attray as Independent Director.
Hindustan Zinc Other Announcement
Hindustan Zinc Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Other acquisition announcements
All →Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Affle 3I Acquisition Worth ₹3,990 Cr
Affle 3i's step-down subsidiary will acquire Perion Network in an all-cash deal valued at about ₹3,990 Crore. Closing is expected in early 2027.
- Value
- ₹3,990 Cr
- Execution
- Expected to close in early 2027
Sai Parenterals Acquisition
Sai Parenterals will acquire the remaining 25% stake in its 75% subsidiary SP Analytics for cash, making it wholly owned. Related-party approval was taken at the 1 November 2026 board meeting, with completion by 31 December 2026.
- Execution
- 31-12-2026
R R Kabel Acquisition Worth ₹77 Cr
R R Kabel completed its acquisition of U M Cables' optical fibre business via slump sale for Rs.77 Crore. The transaction took effect from 31 October 2026.
- Value
- ₹77.00 Cr
R R Kabel Acquisition
R R Kabel completed its acquisition of U M Cables' business undertaking via slump sale, effective 31 October 2026. No consideration amount was disclosed in this intimation.
JSW Steel Acquisition
JSW Steel's scheme to amalgamate Piombino Steel became effective on 31 October 2026. Piombino now stands merged into JSW Steel under the NCLT-sanctioned scheme.